Behzad Mahdavi, Ph.D., MBA
Vice President of Open Innovation, Biologics, Cell and Gene Therapy
With over 20 years’ experience in developing and implementing impactful growth strategies in the biopharmaceutical industries, Dr. Mahdavi joined Catalent in 2020 after a 13-year career at Lonza, where he held the role of Vice President Strategic Innovation & Alliances, and various board-level positions at other innovative companies. Prior to joining Lonza, he was Chief Executive Officer of SAM Electron Technologies, a venture capital-backed company in the life sciences field. He holds a doctorate in chemistry from the University of Sherbrooke, Canada, and also has a master’s in business administration from the University of Quebec in Montreal.
Tine Lewi, Ph.D.
Scientific Director, Janssen R&D/Clinical Innovation.
Dr. Lewi is leading Patient Data For Research initiatives within Janssen Clinical Innovation, introducing novel projects in the area of data science. She has worked for several years in data management and analytics solution development and engages in RWD initiatives to optimise clinical research across the R&D lifecycle. Dr. Lewi has a special interest in using health data for early diagnosis and disease interception, understanding disease trajectories and treatment optimization through RWD. She has a background in medical informatics and applied economics and obtained a doctorate on patient insights and health communication for disease prevention.